ASX:AJX

Stock Analysis Report

Alexium International Group

Executive Summary

Alexium International Group Limited develops and sells specialty chemicals and solutions in Australia and the United States.

Snowflake

Fundamentals

Imperfect balance sheet with weak fundamentals.

Risks

  • Alexium International Group has significant price volatility in the past 3 months.
  • Alexium International Group is not covered by any analysts.

Share Price & News

How has Alexium International Group's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

0%

ASX:AJX

-1.7%

AU Chemicals

-1.7%

AU Market


1 Year Return

-9.7%

ASX:AJX

4.0%

AU Chemicals

1.5%

AU Market

AJX underperformed the Chemicals industry which returned 4% over the past year.

AJX underperformed the Market in Australia which returned 1.5% over the past year.


Share holder returns

AJXIndustryMarket
7 Day0%-1.7%-1.7%
30 Day-15.2%-0.4%-3.2%
90 Day0%-1.5%-0.1%
1 Year-9.7%-9.7%6.8%4.0%7.3%1.5%
3 Year-73.6%-73.6%24.1%14.4%30.7%13.8%
5 Year-3.4%-3.4%35.5%15.4%37.6%7.0%

Price Volatility Vs. Market

How volatile is Alexium International Group's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is Alexium International Group undervalued based on future cash flows and its price relative to the stock market?

8.35x

Price to Book (PB) ratio


Intrinsic Value Based on Future Cash Flows

Unable to calculate intrinsic value for Alexium International Group to establish if it is available at moderate discount.

Unable to calculate intrinsic value for Alexium International Group to establish if it is available at substantial discount.


Price Based on Earnings

Alexium International Group is loss making, we can't compare its value to the AU Chemicals industry average.

Alexium International Group is loss making, we can't compare the value of its earnings to the Australia market.


Price Based on Expected Growth

Unable to calculate PEG ratio for Alexium International Group, we can't assess if its growth is good value.


Price Based on Value of Assets

Alexium International Group is overvalued based on assets compared to the AU Chemicals industry average.


Next Steps

Future Growth

How is Alexium International Group expected to perform in the next 1 to 3 years based on estimates from 0 analysts?

31.5%

Forecasted Materials industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Alexium International Group has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Next Steps

Past Performance

How has Alexium International Group performed over the past 5 years?

-3.5%

Historical annual earnings growth


Earnings and Revenue History


Past Earnings Growth Analysis

Alexium International Group does not make a profit and their year on year earnings growth rate was negative over the past 5 years.

Unable to compare Alexium International Group's 1-year earnings growth to the 5-year average as it is not currently profitable.

Unable to compare Alexium International Group's 1-year growth to the Global Chemicals industry average as it is not currently profitable.


Return on Equity

It is difficult to establish if Alexium International Group has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) as it is loss-making.


Return on Assets

It is difficult to establish if Alexium International Group has efficiently used its assets last year compared to the AU Chemicals industry average (Return on Assets) as it is loss-making.


Return on Capital Employed

It is difficult to establish if Alexium International Group improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.


Next Steps

Financial Health

How is Alexium International Group's financial position?


Financial Position Analysis

Alexium International Group is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.

Alexium International Group's cash and other short term assets cover its long term commitments.


Debt to Equity History and Analysis

Alexium International Group's level of debt (148.6%) compared to net worth is high (greater than 40%).

The level of debt compared to net worth has increased over the past 5 years (23.2% vs 148.6% today).


Balance Sheet

High level of physical assets or inventory.

Debt is covered by short term assets, assets are 1.4x debt.


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Alexium International Group has less than a year of cash runway based on current free cash flow.

Alexium International Group has less than a year of cash runway if free cash flow continues to grow at historical rates of 0.8% each year.


Next Steps

Dividend

What is Alexium International Group's current dividend yield, its reliability and sustainability?


Dividend Yield and Payments Analysis

Unable to evaluate Alexium International Group's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.

Unable to evaluate Alexium International Group's dividend against the top 25% market benchmark as the company has not reported any payouts.

Unable to perform a dividend volatility check as Alexium International Group has not reported any payouts.

Unable to verify if Alexium International Group's dividend has been increasing as the company has not reported any payouts.


Current Payout to Shareholders

Unable to calculate sustainability of dividends as Alexium International Group has not reported any payouts.


Future Payout to Shareholders

Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.


Next Steps

Management

What is the CEO of Alexium International Group's salary, the management and board of directors tenure and is there insider trading?

1.6yrs

Average management tenure


CEO

Bob Brookins 0

1.3yrs

Tenure

US$220,923

Compensation

Dr. Robert Brookins, also known as Bob, Ph. D., M. A. E. B. A. B. Sc., has been the Chief Executive Officer and Managing Director at Alexium International Group Limited since May 31, 2018 and its Director  ...


CEO Compensation Analysis

Bob's remuneration is about average for companies of similar size in Australia.

Bob's compensation has been consistent with company performance over the past year, both up more than 20%.


Management Age and Tenure

1.6yrs

Average Tenure

The average tenure for the Alexium International Group management team is less than 2 years, this suggests a new team.


Board Age and Tenure

1.2yrs

Average Tenure

The average tenure for the Alexium International Group board of directors is less than 3 years, this suggests a new board.


Insider Trading

No 3 month open market individual insider trading information.


Ownership Breakdown


Management Team

  • Bob Brookins

    CEO, MD & Director

    • Tenure: 1.3yrs
    • Compensation: US$220.92k
  • Jason Lewis

    Chief Financial Officer

    • Tenure: 1.6yrs
  • Maja McGuire

    Company Secretary & General Counsel

    • Tenure: 1.5yrs
  • Mark Wise

    Vice President of Investor Relations & Corporate Communications

    • Tenure: 2.6yrs
  • Jessica Hutchison

    Vice President of Human Resources

    • Tenure: 2.6yrs
  • Scott Hunter

    Vice President of Sales

    • Tenure: 0.0yrs
  • Allen Reihman

    Chief Commercial Officer

    • Tenure: 1.6yrs

Board Members

  • Claire Poll (52yo)

    Independent Non-Executive Director

    • Tenure: 1.7yrs
    • Compensation: US$27.54k
  • Steve Cheney

    Deputy Chairman

    • Tenure: 1.3yrs
    • Compensation: US$53.72k
  • Bob Brookins

    CEO, MD & Director

    • Tenure: 1.3yrs
    • Compensation: US$220.92k
  • Rosheen Garnon

    Non-Executive Chairwoman

    • Tenure: 0.4yrs

Company Information

Alexium International Group Limited's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Alexium International Group Limited
  • Ticker: AJX
  • Exchange: ASX
  • Founded:
  • Industry: Diversified Chemicals
  • Sector: Materials
  • Market Cap: AU$48.648m
  • Shares outstanding: 347.49m
  • Website: https://www.alexiuminternational.com

Number of Employees


Location

  • Alexium International Group Limited
  • 125 St Georges Terrace
  • Level 11
  • Perth
  • Western Australia
  • 6000
  • Australia

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
AJXASX (Australian Securities Exchange)YesOrdinary SharesAUAUDMar 2010
E7TDB (Deutsche Boerse AG)YesOrdinary SharesDEEURMar 2010
AJXCHIA (Chi-X Australia)YesOrdinary SharesAUAUDMar 2010
AXXI.YOTCPK (Pink Sheets LLC)SPONSORED ADRUSUSDDec 2011

Biography

Alexium International Group Limited develops and sells specialty chemicals and solutions in Australia and the United States. The company offers flame retardant (FR) treatments, including Alexiflam FR for u ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/08/22 10:37
End of Day Share Price2019/08/22 00:00
Earnings2018/12/31
Annual Earnings2018/06/30


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.